OPC-1 (Geron)

N/A

Report date: 2023/12/01 20:06:44

Base Information

Drug NameOPC-1 (Geron)

Drug Alias NameHuman embryonic stem cell therapy (Geron)hESC-derived oligodendrocyte progenitor cells (OPC)Oligodendrocyte progenitor cellsGRNOPC-1AST-OPC1 +[6]

ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Embryonic stem cells therapy

Mechanisms of ActionStem cell replacements

TargetsNot applicable

Therapy Area/IndicationsSpinal InjuriesSpinal Cord Injuries

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPending (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesGeron Co Asterias Biotherapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesLineage Cell Therapeutics Inc

Active IndicationsN/A

Inactive IndicationsSpinal InjuriesSpinal Cord Injuries

Other Information

ATC CodeN/A